title: Re-evaluation and modification of the Stuivenberg Hospital Acute Renal Failure (SHARF) scoring system for the prognosis of acute renal failure: an independent multicentre, prospective study.
abstract: BACKGROUND
  A prognostic scoring system for hospital mortality in acute renal failure (Stuivenberg Hospital Acute Renal Failure, SHARF score) was developed in a single-centre study. The scoring system consists of two scores, for the time of diagnosis of acute renal failure (ARF) and for 48 h later, each originally based on four parameters (age, serum albumin, prothrombin time and heart failure). The scoring system was now tested and adapted in a prospective study.
  
  
  METHODS
  The study involved eight intensive care units. We studied 293 consecutive patients with ARF in 6 months. Their mortality was 50.5%. The causes of ARF were medical in 184 (63%) patients and surgical in 108 (37%). In the latter group, 74 (69%) patients underwent cardiac and 19 (18%) vascular surgery.
  
  
  RESULTS
  As the performance of the original SHARF scores was much lower in the multicentre study than in the original single-centre study, we re-analysed the multicentre data to customize the original model for the population studied. The independent variables were the score developed in the original study plus all additonal parameters that were significant on univariate analysis. The new multivariate analysis revealed an additional subset of three parameters for inclusion in the model (serum bilirubin, sepsis and hypotension). For the modified SHARF II score, r(2) was 0.27 at 0 and 0.33 at 48 h, respectively, the receiver operating characteristic (ROC) values were 0.82 and 0.83, and the Hosmer-Lemeshow goodness-of-fit P values were 0.19 and 0.05.
  
  
  CONCLUSIONS
  After customizing and by using two scoring moments, this prediction model for hospital mortality in ARF is useful in different settings for comparing groups of patients and centres, quality assessment and clinical trials. We do not recommend its use for individual patient prognosis.
authors.affiliation: Department of Nephrology-Hypertension, ACZA Campus Stuivenberg, Lange Beeldekensstraat 267, B-2060 Antwerpen, Belgium. robert.lins@pro.tiscali.be
authors.forename: R L
authors.initials: RL
authors.lastname: Lins
authors.forename: M M
authors.initials: MM
authors.lastname: Elseviers
authors.forename: R
authors.initials: R
authors.lastname: Daelemans
authors.forename: P
authors.initials: P
authors.lastname: Arnouts
authors.forename: J-M
authors.initials: JM
authors.lastname: Billiouw
authors.forename: M
authors.initials: M
authors.lastname: Couttenye
authors.forename: E
authors.initials: E
authors.lastname: Gheuens
authors.forename: P
authors.initials: P
authors.lastname: Rogiers
authors.forename: R
authors.initials: R
authors.lastname: Rutsaert
authors.forename: P
authors.initials: P
authors.lastname: Van der Niepen
authors.forename: M E
authors.initials: ME
authors.lastname: De Broe
mesh_terms: D058186:Acute Kidney Injury / Q000401:mortality*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D011379:Prognosis; D011446:Prospective Studies; D012720:Severity of Illness Index